After three years, mainland China has opened sea and land crossings with Hong Kong and ended a requirement for incoming travelers to quarantine.
China’s easing over the past month of one of the world’s tightest Covid regimes followedagainst a policy that included frequent testing, curbs on movement and mass lockdowns that heavily damaged the second-biggest economy.
“I’m so happy, so happy, so excited. I haven’t seen my parents for many years,” said Hong Kong resident Teresa Chow as she and dozens of other travellers prepared to cross into mainland China from Hong Kong’s Lok Ma Chau checkpoint early on Sunday. Investors hope the reopening will eventually reinvigorate a $17-trillion economy suffering its lowest growth in nearly half a century. But the abrupt policy reversal hasthat is overwhelming some hospitals and causing business disruptions.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
China reopens borders to tourists after three years of Covid closureIt comes as the world's largest annual migration event, Lunar New Year, begins.
Read more »
China reports three COVID deaths for January 6China reported three new COVID-19 deaths in the mainland for Jan. 6, compared with five deaths a day earlier, the Chinese Center for Disease Control and Prevention said on Saturday.
Read more »
China seeks to minimize COVID-19 risk during travel rushChina is seeking to minimize the possibility of a major new COVID-19 outbreak during this month's Lunar New Year travel rush following the end of most pandemic containment measures
Read more »
China’s latest COVID challenge: Lunar New Year holiday travel surgeChina is hoping to avoid an acceleration in the pace of new COVID cases during the Lunar New Year holiday.
Read more »
Pfizer in talks with China to market COVID-19 antiviral treatment: ReportChina is reportedly in discussions with Pfizer to secure a license for the U.S. drugmaker's COVID-19 antiviral Paxlovid amid a surge in cases in the mainland.
Read more »
Exclusive: China in talks with Pfizer for generic COVID drugChina is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm's COVID-19 antiviral drug Paxlovid in China, three sources told Reuters.
Read more »